Mitochondrial RNA polymerase (POLRMT) is often reported as a target protein for the treatment of malignant tumours [17], however snRNA-activating protein complex 5 (SNAPC5), also named SNAP19 [18], has rarely been reported in tumours. This evidence concerns the gene POLRMT and cancer.